The present study aims to investigate the relationship between the plasma levels of neurofilament light chain in patients with post-acute neurological symptoms (fatigue, cognitive dysfunction, and anxiety) and matched control who presented mild acute COVID-19 and provide information about the potential of NfL as a prognostic biomarker in those cases. The gene discussed is NEFL; the disease is COVID-19.